Advanced Search

 

Study ID Status Title Patient Level Data
100561 (Y6) Completed Long-Term Follow-up Study to Evaluate the Immune Persistence of GSK Biologicals' Combined Hepatitis A / Hepatitis B Vaccine in Healthy Children
100566 Completed Evaluate Persistence of Immune Response of GSK Biologicals’ TWINRIX™ Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX™ JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 years at Time of First Vaccine Dose Study Listed on ClinicalStudyDataRequest.com
100571 (M138) Completed Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Study Listed on ClinicalStudyDataRequest.com
100576 (Y11) Completed Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Study Listed on ClinicalStudyDataRequest.com
100601 Completed LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Study Listed on ClinicalStudyDataRequest.com
100614 Completed SUccessful Control and Clinical Effectiveness of SERETIDE study in aSthma, a randomised controlled study to investigate the clinical effectiveness and health outcome of SERETIDE in patients with moderate and severe persistent asthma in Korea
100633 Completed A multicenter, open-label Phase I/II trial of the safety and efficacy of the dHER2 recombinant protein combined with immunological adjuvant AS15 in patients with metastatic breast cancer overexpressing HER2/neu Study Listed on ClinicalStudyDataRequest.com
100684 Completed A Single-blind, Randomised, Positive-controlled, Parallel-group Multicentre Study to Compare the Effect of Glibenclamide plus Rosiglitazone vs Glibenclamide plus Placebo on Body Fat Distribution When Administered for 12 Months to Korean Patients with Type 2 Diabetes Mellitus.
100732 Completed A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908 (700mg BID) plus ritonavir (100mg BID) Versus Lopinavir/ritonavir (400mg/100mg BID) when Administered in Combination with the Abacavir/Lamivudine (600mg/300mg) Fixed-Dose Combination Tablet QD in Antiretroviral-Naive HIV-1 Infected Adults Over 48 Weeks
100791 Completed Partially blinded study to assess reactogenicity & safety of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ in healthy infants after a hepatitis B birth dose
100901 Terminated An open label extension study to evaluate safety and efficacy of mepolizumab in patients with hypereosinophilic syndromes Study Listed on ClinicalStudyDataRequest.com
100917 Completed An open, multicentric, post-marketing surveillance study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals' DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months of age, in healthy infants. Study Listed on ClinicalStudyDataRequest.com
101182 Completed Single-centre randomised open crossover study to examine the influence of different internal resistances of discus and turbohaler respectively on the effects of salmeterol and formoterol in asthmatic subjects
101464 Completed A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of a Flexible Dose of Lamotrigine Compared to Placebo as an Adjunctive Therapy to an Atypical Antipsychotic Agent(s) in Subjects with Schizophrenia Study Listed on ClinicalStudyDataRequest.com
101468/169 Completed A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment with Ropinirole CR as Adjunctive Therapy in Patients with Parkinson's Disease who are not Optimally Controlled on L-dopa Study Listed on ClinicalStudyDataRequest.com
101468/196 Completed 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Study Listed on ClinicalStudyDataRequest.com
101468/204 Completed A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared with Ropinirole Immediate Release (IR) Tablets in Subjects with Restless Legs Syndrome (RLS) Study Listed on ClinicalStudyDataRequest.com
101468/205 Completed A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole XR (Extended Release) in Patients with Restless Legs Syndrome Study Listed on ClinicalStudyDataRequest.com
101468/206 Completed A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients with Restless Legs Syndrome (RLS) Study Listed on ClinicalStudyDataRequest.com
101468/228 Completed A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Study Listed on ClinicalStudyDataRequest.com
101468/248 Completed An Open-Label Extension Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Study Listed on ClinicalStudyDataRequest.com
101468/249 Completed A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Study Listed on ClinicalStudyDataRequest.com
101468/253 Completed A study to determine the tolerability and pharmacokinetics for ropinirole in paediatric / adolescent patients with RLS (Type 2) Study Listed on ClinicalStudyDataRequest.com
101477 Completed Assess the immunogenicity and reactogenicity of a booster dose of a formulation of GSK Biologicals’ DTPw-HBV/Hib vaccine at 15-18 mths of age in infants previously primed with the same vaccine
101653 Completed A centre-randomized, open-label, cross-over study to compare the pharmaco-economic consequences of an Ultiva (remifentanil hydrochloride) based regimen with conventional sedative based regimens in ICU subjects requiring short-term mechanical ventilation with analgesia and sedation

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.